OTC Markets Stock News
Biotech
-
30.9KWhy RLFTF Stock Is The Best COVID-19 Bet
Right now a lot of traders and investors are asking what the next move to make in regards to COVID-19 plays. Many...
-
23.3K1CytoDyn (OTCMKTS:CYDY) May Make the White House Podium
CytoDyn Inc. (OTCMKTS:CYDY) may be the target of a White House press briefing very soon. A couple of social media influencers like...
-
4.6KIs RIGL Stock Gearing Up For A Big Move?
RIGL stock exploded higher last month after instigating an investigator-sponsored trial (IST) with the Imperial College London to evaluate the efficacy of...
-
11.3KTonix Pharmaceuticals: A Bull Run Is Coming
Tonix Pharmaceuticals is a name that we covered last month before its run to $2.50, which you can read here. What attracted...
-
14.7KHTBX Stock: The Solution Is T-Cells Not Antibodies
No one ever said investing is easy. The key is doing lots of research and finding momentum BEFORE it happens. We did...
-
3.8KATOS Stock: What’s Happening?
ATOS stock is a name that we covered on and off since 2017. Except for a few price spikes, ATOS stock has been...
-
9.6KVBI Vaccines Stock Destined For New Highs
VBI Vaccines stock has dropped along with the other COVID-19 vaccine players after Russia announced it developed a coronavirus vaccine. Like many...
-
22.2KSorrento Therapeutics Stock: Ignore Hindenburg
A thorn in the side of longs continues to be Hindenburg Research. Whenever a hot stock starts climbing, Hindenburg goes short and...
-
6.2KBCRX Stock Just Gave A Clear Buy Signal
BCRX stock ran to $6 after re-initiated coverage last month, which you can read here. Since then, BCRX has dropped back down...
-
15.0K2Wading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
